Needham & Company downgraded Heron Therapeutics stock rating, while MarketBeat provided average stock rating data.
1 report, 1 independent
Updated Sep 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company downgraded Heron Therapeutics stock rating, while MarketBeat provided average stock rating data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Needham & Company
American independent investment bank and asset management firm
Related events
- MarketBeat reported an average stock rating for Superior Group of Companies.
- MarketBeat reported average stock rating for I-Mab on September 9, 2026.
- MarketBeat reported an average stock rating for ATA Creativity Global.
- MarketBeat reported recent stock ratings for Innovative Solutions and Support, Inc. and TechPrecision Corporation.
- MarketBeat reported the stock average rating for Range Capital Acquisition Corp., a company that trades on the Nasdaq exchange.